Skip to main content
. 2017 Jun 30;28(10):2915–2930. doi: 10.1681/ASN.2016111211

Figure 8.

Figure 8.

AS ODN against Cx43 preserve renal function after NTS-GN. (A and B) Administration of AS ODN decreases Cx43 expression. The NTS-induced increase of (C) body weight, (D) proteinuria, (E) creatininemia, and (F) BUN is attenuated in wild-type mice treated with Cx43 AS ODN. Body weight increase is presented as weight (grams) gained since the beginning of the protocol. *P<0.05; **P<0.01; ***P<0.001.